More stories >

Patient Story: Kevin Manion

March 22, 2024

Having been fairly healthy throughout his life, Kevin and his family faced increasing hardships after he experienced not one, but three heart attacks by age 57. After his fourth heart attack, Kevin came to Abbott Northwestern Hospital where he met Dr. Kasia Hryniewicz and learned just how damaged his heart had become.

Kevin’s fourth heart attack was the most serious kind, referred to as STEMI, and it left his heart damaged and unable to effectively pump blood throughout his body. He needed a left ventricular assist device (LVAD), a mechanical pump that is implanted inside the chest to help a weakened heart pump blood.

For one year Kevin’s LVAD worked well, but after catching an infection his only option left was waiting for a donor to receive a heart transplant. Kevin soon received a call from a research coordinator at the Minneapolis Heart Institute Foundation about a new research study for patients like him in need of a heart transplant.

“There was just never a question in my mind,” said Kevin. “Why wouldn’t I participate in research? I want to do something to help. I’m 57 now, so I’m at a stage in life where I’m looking to contribute in any way I can. I agreed wholeheartedly to participate.”

Nobody mentioned a timeline for the research study or how quickly a heart would become available for Kevin, but within a week he received the call that they’d found a heart and could proceed with the transplant.

Give the Gift of Hope

4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background

Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.